Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease

Ilaria Cova1, Francesca Clerici1, Annalia Rossi1

  • 1Center for Research and Treatment on Cognitive Dysfunctions, Biomedical and Clinical Sciences Department, "Luigi Sacco" Hospital, University of Milan, Milan, Italy.

Plos One
|March 19, 2016
PubMed
Abstract

Insights

Significant weight loss in individuals with Mild Cognitive Impairment (MCI) predicts a faster progression to dementia, including Alzheimer's disease (AD). Monitoring weight is crucial for early detection and intervention in MCI patients.

Area of Science:

  • Neurology
  • Geriatrics
  • Clinical Research

Background:

  • Weight loss is a common symptom in Alzheimer's disease (AD).
  • It may serve as an early marker for AD in Mild Cognitive Impairment (MCI), potentially improving prognostic accuracy.
  • Investigating weight loss as a predictor in MCI is crucial for understanding disease progression.

Purpose of the Study:

  • To determine if weight loss predicts the onset of dementia and Alzheimer's disease (AD) in individuals with MCI.
  • To assess the prognostic value of weight changes in MCI patients.

Main Methods:

  • A cohort of 125 MCI subjects (mean age 73.8 years) was followed for approximately 4 years.
  • Weight was measured at least one year apart, with weight loss defined as a ≥4% decrease from baseline.
  • Dementia and AD diagnoses followed established criteria (DSM-IV and NINCDS-ADRDA, respectively).

Main Results:

  • Over 42% of MCI participants progressed to dementia, with half diagnosed with AD.
  • Weight loss was linked to a 3.4-fold increased risk of dementia and a 3.2-fold increased risk of AD.
  • Weight loss was associated with an earlier onset of dementia (2.3 years) and AD (2.5 years).

Conclusions:

  • Weight loss in MCI patients indicates an accelerated progression to dementia and AD.
  • Close monitoring of weight in elderly individuals with MCI is recommended.
  • Weight changes can be a valuable indicator for predicting dementia risk in MCI.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
672